Assetmark, Inc Exelixis, Inc. Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 96 shares of EXEL stock, worth $3,246. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$3,246

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$21.96 - $27.6 $2,108 - $2,649	96 New	96 $2,000
Q2 2023 Aug 11, 2023	SELL	$18.17 - $20.48 $230,686 - $260,014	-12,696 Reduced 99.8%	25 $0
Q1 2023 May 05, 2023	SELL	$16.3 - $19.41 $294,655 - $350,874	-18,077 Reduced 58.7%	12,721 $246,000
Q4 2022 Feb 10, 2023	BUY	$14.96 - $17.39 $104,675 - $121,677	6,997 Added 29.4%	30,798 $493,000
Q3 2022 Nov 01, 2022	BUY	$15.68 - $22.27 $254,486 - $361,442	16,230 Added 214.37%	23,801 $373,000
Q2 2022 Aug 03, 2022	BUY	$17.44 - $23.16 $104,047 - $138,172	5,966 Added 371.71%	7,571 $158,000
Q1 2022 May 13, 2022	BUY	$17.03 - $22.67 $27,333 - $36,385	1,605 New	1,605 $36,000
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $3,736 - $4,590	-182 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$18.39 - $24.8 $698 - $942	-38 Reduced 17.27%	182 $4,000
Q2 2020 Aug 11, 2020	BUY	$16.46 - $27.42 $3,621 - $6,032	220 New	220 $5,000
Q1 2019 May 14, 2019	SELL	$19.6 - $24.76 $705 - $891	-36 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$13.65 - $21.8 $491 - $784	36 New	36 $1,000
Q1 2018 May 16, 2018	SELL	$22.15 - $31.89 $221 - $318	-10 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$23.35 - $29.24 $233 - $292	10	10 $0

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.13 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$991 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$859 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$519 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$387 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account